PCC = Pennsylvania Convention Center ASRM 75TH SCIENTIFIC CONGRESS • SCHEDULE AT A GLANCE Simultaneous live Spanish and Mandarin Chinese Translations of all MONDAY, OCTOBER 14, 2019 Lectures and Symposia in Exhibit Hall C TIME LOCATION ACTIVITY/PRESENTERS
7:00 am – 7:45 am PCC Exhibit Hall C Hallway Opening Ceremony Continental Breakfast
7:45 am - 8:30 am PCC Exhibit Hall C Opening Ceremony
8:30 am - 9:15 am PCC Exhibit Hall C Plenary Lecture 1: President’s Guest Lecture: Closing the Generational Gap Between Practitioners and Patients (Ryan Jenkins)
9:15 am - 10:00 am PCC Exhibit Hall C Plenary Lecture 2: Camran Nezhat, M.D. Lectureship in Innovations in Medicine: Using Live Imaging to Reveal the Mechanisms that Form the Mammalian Embryo (Nicholas Plachta, Ph.D.)
10:00 am - 10:45 am PCC Expo Hall Break – Visit the Expo Hall
10:45 am - 12:15 pm Oral Abstract Sessions
PCC Exhibit Hall C PP01 SCIENTIFIC CONGRESS PRIZE PAPER SESSION 1 PCC 104B OR01-05 ENVIRONMENT AND REPRODUCTION SPERM ASPIRATION (MIESA) RESULTS IN NON-INFERIOR IVF 10:45 AM O-1 ANTIDEPRESSANT MEDICATION EXPOSURE: 10:45 AM O-31 EFFECT OF WILDFIRE SMOKE ON PREGNANCY OUTCOMES COMPARED WITH NORMAL EJACULATED SEMEN IN TIME TO PREGNANCY AND RISK OF PREGNANCY LOSS. L. A. Sjaarda OUTCOMES IN THE NON-HUMAN PRIMATE. B. E. Willson COUPLES WITH UNEXPLAINED INFERTILITY. S. Hayon 11:00 AM O-2 EFFECTS OF FOLIC ACID AND ZINC 11:00 AM O-32 STRESS AND SUCCESS: DATA FROM A 11:45 AM O-59 GONADAL END ORGAN EFFECTS IN MALE TO SUPPLEMENTATION IN MEN ON SEMEN QUALITY AND LIVE BIRTH PROSPECTIVE COHORT INVESTIGATING THE IMPACT OF EARLY LIFE FEMALE TRANSGENDER PATIENTS ON HORMONAL THERAPY. AMONG COUPLES UNDERGOING INFERTILITY TREATMENT: FINDINGS STRESS ON IVF OUTCOMES. J. R. Walter P. Bearelly FROM THE FAZST RANDOMIZED TRIAL. E. F. Schisterman 11:15 AM O-33 PESTICIDE RESIDUE INTAKE FROM FRUIT AND 12:00 PM O-60 THE UTILITY OF SPERM CRYOPRESERVATION AT 11:15 AM O-3 CAN HYSTEROSALPINGO FOAM SONOGRAPHY VEGETABLE CONSUMPTION AND RISK OF LAPAROSCOPICALLY- THE TIME OF VASECTOMY REVERSAL. J. A. Marinaro (HYFOSY) REPLACE HYSTEROSALPINGOGRAPHY (HSG) AS FIRST CONFIRMED ENDOMETRIOSIS. H. Harris PCC 113B OR01-10 NUTRITION CHOICE TUBAL PATENCY TEST: A RANDOMIZED COMPARISON (FOAM 11:30 AM O-34 BLOOD CADMIUM ASSOCIATED WITH HIGHER 10:45 AM O-61 PRECONCEPTION MARIJUANA USE, STUDY)? N. van Welie TESTOSTERONE AND ANTI-MÜLLERIAN HORMONE IN HEALTHY ANOVULATION, AMH, AND PREGNANCY OUTCOMES. S. L. Mumford 11:30 AM O-4 MALE MARIJUANA USE AND SPONTANEOUS PREMENOPAUSAL WOMEN. K. Kim 11:00 AM O-62 SERUM OMEGA-3 AND OMEGA-6 FATTY ACID ABORTION. A. F. Harlow 11:45 AM O-35 THE ASSOCIATION OF URINARY CONCENTRATIONS AND FECUNDITY. J. Stanhiser 11:45 AM O-5 BEETROOT, WATERMELON AND GINGER JUICE CONCENTRATIONS OF BISPHENOL-A, AND DI-ETHYLHEXYL 11:15 AM O-63 THE ROLE OF MATERNAL PRECONCEPTION SUPPLEMENTATION MAY INCREASE THE CLINICAL OUTCOMES OF PHTHALATE METABOLITES WITH THYROID FUNCTION & VITAMIN D STATUS IN HUMAN OFFSPRING SEX RATIO. INTRACYTOPLASMIC SPERM INJECTION CYCLES. D. P. Braga AUTOIMMUNITY IN WOMEN FROM A FERTILITY CENTER: RESULTS A. C. Purdue-Smithe 12:00 PM O-6 PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY FROM THE ENVIRONMENT AND REPRODUCTIVE HEALTH STUDY. 11:30 AM O-64 CAFFEINATED BEVERAGE INTAKE AND SERUM OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND I. Souter CAFFEINE METABOLITES AND RISK OF PREGNANCY LOSS. ADENOMYOSIS. O. Muneyyirci-Delale 12:00 PM O-36 NON-CHRONIC PRECONCEPTION OPIOID USE A. C. Purdue-Smithe PCC 204A OR01-01 ART LAB: BASIC AND REPRODUCTIVE OUTCOMES. K. S. Flannagan 11:45 AM O-65 LEPTIN IS A MEDIATOR IN THE ASSOCIATION 10:45 AM O-7 IMPLEMENTATION OF AN ELECTRONIC PCC 111AB OR01-06 GENETIC COUNSELING BETWEEN PERCENT BODY FAT AND DECREASED AMH AMONG WHITEBOARD FOR QUALITY MANAGEMENT IN THE IN VITRO 10:45 AM O-37 LESSONS LEARNED FROM EVALUATING HEALTHY WOMEN. J. Aly FERTILIZATION LABORATORY. P. A. Romanski DECISIONAL REGRET SURROUNDING PREIMPLANTATION GENETIC 12:00 PM O-66 OMEGA-3 FATTY ACID SUPPLEMENTATION AND 11:00 AM O-8 THE CLINICAL RESULTS OF PIEZO-ICSI COMPARED TESTING FOR ANEUPLOIDY. A. Wijekoon FECUNDABILITY. J. Stanhiser TO CONVENTIONAL-ICSI: A SIBLING-OOCYTE STUDY. N. Okuyama 11:00 AM O-38 FOCUSING ON PARENTAL ORIGIN OF PCC 105AB OR01-11 OVARIAN STIMULATION 11:15 AM O-9 WOULD AN AUTOMATED SYSTEM DETECTING ANEUPLOIDY: DOES PATERNAL AGE IMPACT ANEUPLOIDY RATES IN 10:45 AM O-67 A COMPUTERIZED DECISION –SUPPORT SYSTEM EMBRYO DEVELOPMENTAL EVENTS SELECT THE SAME EMBRYO AS EMBRYOS? K. Merrion FOR DAY TO DAY MANAGEMENT OF OVARIAN STIMULATION CYCLES AN EMBRYOLOGIST USING A MORPHOKINETIC ALGORITHM? 11:15 AM O-39 DO BRCA MUTATIONS IMPACT ANEUPLOIDY DURING IN VITRO FERTILIZATION. G. S. Letterie R. Del Gallego RATES IN EMBRYOS? N. Wemmer 11:00 AM O-68 DUAL TRIGGERING OF FINAL OOCYTE 11:30 AM O-10 PROPORTION OF PATIENTS DETECTED WITH 11:30 AM O-40 THE TP53 GENE (rs1625895) C>T MATURATION IN POOR OVARIAN RESPONDERS: A PROSPECTIVE SUBCLINICAL HYPOTHYROIDISM IS INDEPENDENT OF TIME OF POLYMORPHISM IS ASSOCIATED WITH OVARIAN RESERVE AND RANDOMIZED CONTROLLED TRIAL. D. Khalife BLOOD DRAW. C. Briton-Jones OVARIAN RESPONSE TO RECOMBINANT FSH DURING IVF/ICSI 11:15 AM O-69 RISK OF HARM ASSOCIATED WITH THE USE OF 11:45 AM O-11 PRELIMINARY RESULTS FROM THE FIRST TREATMENT. J. A. Oliveira LETROZOLE AS A FERTILITY DRUG: A SYSTEMATIC REVIEW AND META- REGISTERED PILOT TRIAL WITH MATERNAL SPINDLE TRANSFER TO 11:45 AM O-41 NON-INVASIVE PRENATAL TESTING HAS ANALYSIS. J. Pundir OVERCOME INFERTILITY. N. Costa-Borges ALTERED POSITIVE PREDICTIVE VALUE FOLLOWING TRANSFER OF A 11:30 AM O-70 PREMATURE LUTEINIZATION IN THE ERA 12:00 PM O-12 EFFECT OF SPERM SELECTION USING MACS EUPLOID BLASTOCYST. A. M. Klimczak OF PGT-A: EMBRYONIC REPRODUCTIVE POTENTIAL IS NOT TECHNOLOGY IN THE PGT-A PROGRAM COMPARED WITH STANDARD 12:00 PM O-42 SONOGRAPHIC ABNORMALITIES IN AFFECTED BY ELEVATED PROGESTERONE LEVELS DURING OVARIAN SPERM PREPARATION. M. Meseguer PREGNANCIES CONCEIVED FOLLOWING IVF WITH AND WITHOUT HYPERSTIMULATION. C. Hernandez-Nieto PCC 103A OR01-02 ART OFFSPRING PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY. 11:45 AM O-71 DETERMINING CORRELATION BETWEEN BODY 10:45 AM O-13 THIRD GRADE ACADEMIC ACHIEVEMENT AMONG C. Riestenberg MASS INDEX AND MINIMUM REQUIRED HCG DOSE WHEN USING CHILDREN CONCEIVED WITH IVF: A POPULATION-BASED STUDY IN PCC 103B OR01-07 HEALTH DISPARITIES DUAL TRIGGER WITH HCG AND GnRH AGONIST. L. D. Zimmerman TEXAS. B. Luke 10:45 AM O-43 COMPARISON OF EUPLOID RATES VIA 12:00 PM O-72 EFFECT OF DEHYDROEPIANDROSTERONE 11:00 AM O-14 SEX DIFFERENCES IN BIRTH OUTCOMES FOR PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) (DHEA) SUPPLEMENTATION ON INTRACYTOPLASMIC SPERM MASSACHUSETTS INFANTS FOLLOWING ART. S. S. Hwang AND SUBSEQUENT PREGNANCY OUTCOMES BETWEEN ASIAN AND INJECTION OUTCOME IN INFERTILE WOMEN WITH ANTICIPATED 11:15 AM O-15 CONCEPTION BY INFERTILITY TREATMENT AND WHITE PATIENTS. D. Huang NORMO-OVARIAN RESPONSE. A. M. Abbas NEWBORN DNA METHYLATION. E. Yeung 11:00 AM O-44 INTERSECTION OF SEXUALLY TRANSMITTED PCC BALLROOM AB OR01-12 PREIMPLANTATION GENETIC TESTING 11:30 AM O-16 BABIES BORN FOLLOWING ADMINISTRATION OF INFECTIONS AND SUBSTANCE USE AMONG LOW-INCOME MINORITY 10:45 AM O-73 PGT FOR ANEUPLOIDY IMPROVES PERINATAL NOLASIBAN BEFORE EMBRYO TRANSFER (ET) AFTER IVF: NEONATAL WOMEN: ROUTINE CARE AS A CRITICAL POINT FOR REDUCING OUTCOMES COMPARED WITH FET ALONE: AN ANALYSIS OF THE 2014 AND INFANT DEVELOPMENT OUTCOMES FROM A DOUBLE-BLIND, REPRODUCTIVE HEALTH DISPARITIES. T. McClung AND 2015 SART DATA. K. Van Heertum PLACEBO-CONTROLLED, CLINICAL TRIAL. E. Loumaye 11:15 AM O-45 ANTI-MÜLLERIAN HORMONE (AMH) 11:00 AM O-74 DOES PREIMPLANTATION GENETIC TESTING 11:45 AM O-17 SIMILAR SUCCESS RATES WITH FROZEN TRAJECTORIES IN REPRODUCTIVE AGED AFRICAN-AMERICAN FOR ANEUPLOIDY (PGT-A) HARM EMBRYOS? NO—A MULTI-CENTER, OOCYTES BUT INCREASED RATE OF LARGE FOR GESTATIONAL AGE WOMEN: FINDINGS FROM THE STUDY OF OVARIAN AGING AND PROSPECTIVE, BLINDED, NON-SELECTION STUDY EVALUATING THE (LGA) INFANTS COMPARED TO FRESH OOCYTES. C. Burks RESERVE (SOAR). E. Giuliani PREDICTIVE VALUE OF AN ANEUPLOID DIAGNOSIS AND IMPACT OF 12:00 PM O-18 PREVALENCE OF CLINICALLY SIGNIFICANT 11:30 AM O-46 PERSISTENT WIDENING IN RACIAL DISPARITIES BIOPSY A. W. Tiegs CONGENITAL HEART DEFECTS IN LOW-RISK IVF PREGNANCIES. S. H. BETWEEN BLACK AND WHITE WOMEN UNDERGOING ART OVER THE 11:15 AM O-75 PREIMPLANTATION GENETIC TESTING (PGT) IS Bjorkman LAST 10 YEARS. A. Kotlyar ASSOCIATED WITH HIGHER ODDS OF A HEALTHY LIVEBIRTH AMONG PCC 106B OR01-03 CONTRACEPTION AND COMPLEX FAMILY PLANNING 11:45 AM O-47 SOUTH ASIAN WOMEN HAVE POORER IVF DONOR OOCYTE RECIPIENTS IN THE UNITED STATES: A 2013-2015 10:45 AM O-19 TOPICAL LIDOCAINE-PRILOCAINE CREAM VERSUS OUTCOMES DESPITE BEING YOUNGER AND HAVING BETTER NATIONAL STUDY. C. Roeca LIDOCAINE 1% SUBCUTANEOUS INFILTRATION DURING NEXPLANON OVARIAN RESERVE COMPARED TO CAUCASIANS. F. I. Sharara 11:30 AM O-76 PREGNANCY OUTCOMES FOLLOWING IN VITRO INSERTION: A RANDOMIZED CONTROLLED STUDY. A. M. Abbas 12:00 PM O-48 REGIONAL DISPARITIES IN ASSISTED FERTILIZATION FROZEN EMBRYO TRANSFER (IVF-FET) WITH OR 11:00 AM O-20 A RANDOMIZED CLINICAL TRIAL BETWEEN REPRODUCTIVE TECHNOLOGY ACCESS TO CARE: EMPLOYING WITHOUT PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY ULTRASOUND-GUIDED AND UTERINE SOUND-SPARING APPROACH MODERN TECHNOLOGY TO CLOSE THE GAP. S. Mikhael (PGT-A) IN WOMEN WITH RECURRENT PREGNANCY LOSS (RPL): A FOR COPPER INTRAUTERINE DEVICE INSERTION. A. M. Abbas PCC 103C OR01-08 INFERTILITY AND CANCER SART-CORS STUDY. S. Bhatt 11:15 AM O-21 EFFECT OF CELL-PHONE ASSISTED 10:45 AM O-49 PREGNANCIES IN CANCER SURVIVORS: OVARIAN 11:45 AM O-77 CONCURRENT PRE-IMPLANTATION GENETIC POSTPARTUM COUNSELING ON THE USE OF LONG-ACTING RESERVE IS A POOR PROGNOSTICATOR. J. A. Suyama TESTING FOR SINGLE GENE DISORDERS AND ANEUPLOIDY REVERSIBLE CONTRACEPTIVES: A RANDOMIZED CONTROLLED 11:00 AM O-50 THE POTENTIAL IMPACT OF NEWER SCREENING FROM A SINGLE TROPHECTODERM (TE) BIOPSY USING TRIAL. O. M. Shaaban CHEMOTHERAPY REGIMENS ON FUTURE FERTILITY IN MEN AND TARGETED NEXT GENERATION SEQUENCING (NGS) WITHOUT 11:30 AM O-22 INFLUENCE OF GENETIC VARIANTS ON WEIGHT WOMEN TREATED FOR LYMPHOMA. D. Garg WHOLE GENOME AMPLIFICATION (WGA). H. Garnsey GAIN AMONG ETONOGESTREL CONTRACEPTIVE IMPLANT USERS. 11:15 AM O-51 CANCER TREATMENT IS ASSOCIATED WITH A 12:00 PM O-78 MOSAIC EMBRYOS - A COMPREHENSIVE AND A. Lazorwitz MEASURABLE DECREASE IN LIVE BIRTHS IN A LARGE, POPULATION- POWERED ANALYSIS OF CLINICAL OUTCOMES. M. Viotti 11:45 AM O-23 EFFICACY AND SAFETY OF A MULTIPURPOSE BASED STUDY. D. Garg PCC 113C OR01-13 REPRODUCTIVE BIOLOGY: HUMAN STUDIES VAGINAL pH-REGULATOR: RESULTS FROM THE PHASE 3, AMPOWER 11:30 AM O-52 PREGNANCY OUTCOMES AMONG CANCER 10:45 AM O-79 THE RELATIONSHIP BETWEEN CHRONOLOGIC CONTRACEPTION CLINICAL TRIAL. M. A. Thomas SURVIVORS: A POPULATION-BASED ANALYSIS. D. Garg AGE, OVARIAN RESPONSE, AND DNA METHYLATION OF WHITE 12:00 PM O-24 BLEEDING PATTERNS AND ENDOMETRIAL 11:45 AM O-53 STIMULATION OF THE OVARIES IN WOMEN BLOOD CELLS AND CUMULUS CELLS AMONG INFERTILE WOMEN SAFETY WITH A 1-YEAR, SEGESTERONE ACETATE/ETHINYL WITH BREAST CANCER UNDERGOING FERTILITY PRESERVATION: UNDERGOING IVF. B. M. Hanson ESTRADIOL CONTRACEPTIVE VAGINAL SYSTEM. D. F. Archer ALTERNATIVE VERSUS STANDARD STIMULATION PROTOCOLS. 11:00 AM O-80 THE INCLUSION OF BLASTOMERES INTO THE PCC 107AB OR01-04 CRYOPRESERVATION & FROZEN EMBRYO TRANSFER E. M. Balkenende INNER CELL MASS IN EARLY-STAGE HUMAN EMBRYOS DEPENDS 10:45 AM O-25 UNIVERSAL WARMING PROTOCOL” FOR A 12:00 PM O-54 DESCRIBING LIVE BIRTHS AFTER CANCER ON THE SEQUENCE OF CELL CLEAVAGES DURING THE FOURTH TRANSNATIONAL EGG DONATION PROGRAM WITH VITRIFIED TREATMENTS: WHEN DO PATIENTS CONCEIVE AND HOW MANY DIVISION. J. Otsuki OOCYTES: A RETROSPECTIVE MULTI-CENTRE STUDY. L. L. Parmegiani CHILDREN DO THEY HAVE? A POPULATION-BASED STUDY IN THE 11:15 AM O-81 THE EFFECT OF AGE ON BIOENERGETICS OF 11:00 AM O-26 MORPHOLOGY STILL MATTERS WHEN WESTERN UNITED STATES D. Garg HUMAN GRANULOSA CELLS. G. N. Cecchino SELECTING EUPLOID EMBRYOS: INNER CELL MASS (ICM) AND PCC 113A OR01-09 MALE REPRODUCTION AND UROLOGY: 11:30 AM O-82 REPEATED IMPLANTATION FAILURE PATIENTS TROPHECTODERM (TE) ARE PREDICTIVE OF PREGNANCY TRAVELING SCHOLARS DISPLAYS A GREATER DELAY OF THEIR RECEPTIVITY WINDOW OUTCOMES. S. Druckenmiller 10:45 AM O-55 EVALUATION OF FERTILITY PRESERVATION DIAGNOSED USING A GENOMIC TEST UNDER HRT TREATMENT 11:15 AM O-27 CLINICAL FACTORS ASSOCIATED WITH THAW COUNSELING AND REFERRALS IN US CLINICAL PRACTICES: REVIEW COMPARED TO NATURAL CYCLES. D. Haouzi SURVIVAL IN A COHORT OF 6167 VITRIFIED-WARMED, EUPLOID OF ASCO’S QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI). 11:45 AM O-83 THE ROLE OF VITAMIN D AS A PIECE OF THE BLASTOCYSTS. M. Oliva T. P. Kohn UTERINE FACTOR INFERTILITY PUZZLE. K. Matevossian 11:30 AM O-28 ANTIOXIDANTS INCREASE BLASTOCYST 11:00 AM O-56 LOWER TOTAL MOTILE COUNT IS ASSOCIATED 12:00 PM O-84 DYNAMIC DNA METHYLATION DURING CRYOSURVIVAL AND VIABILITY POST VITRIFICATION. T. T. Truong WITH SMALLER HISTORIC INTERGENERATIONAL FAMILY SIZE: A TROPHOBLAST DIFFERENTIATION IN HUMAN PERI-IMPLANTATION 11:45 AM O-29 DIFFERENCES IN OOCYTE SURVIVAL BETWEEN PEDIGREE ANALYSIS FROM THE UTAH POPULATION DATABASE STAGE EMBRYOS REVEALED BY SINGLE-CELL WHOLE GENOME DONOR EGG BANKS AND SATELLITE CLINICS WITHIN THE SAME (UPDB). D. P. Patel BISULFITE SEQUENCING. Y. Yuan COMPANY. W. Hewitt 11:15 AM O-57 DECISIONAL CONFLICT AND KNOWLEDGE PCC 108B OR01-14 REPRODUCTIVE SURGERY AND PROCEDURES 12:00 PM O-30 IMPROVED EMBRYOLOGY OUTCOME AND AMONG PATIENTS WITH VARICOCELE SEEKING TREATMENT FOR 10:45 AM O-85 A SURVEY OF MICROSURGERY TRAINING AMONG MORPHOKINETIC CHARACTERISTICS OF EMBRYOS DERIVED FROM INFERTILITY. R. Jayadevan UROLOGY RESIDENCY PROGRAMS. T. A. Masterson FROZEN/THAWED OOCYTES INJECTED 3 VERSUS 2 HOURS POST- 11:30 AM O-58 SPERM EXTRACTED FROM MEN WITH 11:00 AM O-86 OUTCOME OF LAPAROSCOPIC ADHESIOLYSIS WARMING. C. Norberg OBSTRUCTIVE AZOSPERMIA VIA MINIMALLY-INVASIVE EPIDIDYMAL IN INFERTILE PATIENTS WITH PELVIC ADHESIONS FOLLOWING
Monday Oct 14.indd 1 9/9/19 10:02 AM PCC = Pennsylvania Convention Center Simultaneous live Spanish and Mandarin Chinese MONDAY, OCTOBER 14, 2019 Translations of all Lectures and Symposia in Exhibit Hall C
CESAREAN DELIVERY: A RANDOMIZED CLINICAL TRIAL. A. a. Algergawy 11:30 AM O-88 UTERUS TRANSPLANTATION - LIVING DONOR 12:00 PM O-90 SINGLE EUPLOID FROZEN EMBRYO 11:15 AM O-87 RESULTS OF CROMOSOMAL ANALYSIS OF OUTCOME. L. Johannesson TRANSFER: EVALUATING IMPACT OF INTERVAL SINCE OPERATIVE PRODUCTS OF CONCEPTION USING TARGETED DIRECT EMBRYO 11:45 AM O-89 PREGNANCY OUTCOMES FOLLOWING HYSTEROSCOPY. A. C. Petrini BIOPSY BY OPERATIVE HYSTEROSCOPY. J. Rouleau HYSTEROSCOPIC CORRECTION OF T-SHAPED UTERI. S. A. Neal
11:00 am - 12:00 pm PCC 201A MHPG Clinical Session: Research Isn’t Just for Nerds: The Easy How-To’s of Conducting Publishable Research in the Field of Reproductive Medicine (Alice Domar, Ph.D., Lauri Pasch, Ph.D.)
12:15 pm - 1:15 pm PCC Expo Hall Break/Lunch – Visit the Expo Hall
12:15 pm - 1:15 pm PCC 104A Expert Encounter: Venture Capital, Private Equity, and Assisted Reproduction: Investing in Innovation in IVF (David Sable, M.D.)
12:15 pm - 1:15 pm PCC Expo Roundtable Area Roundtables RTM1 Disparities in Male Reproductive Health RTM15 Legal and Ethical Considerations When Representing the RTM28 Understanding Mosaicism – What You Need to Know (Jim Dupree, M.D., M.P.H.) “Non-Traditional” Family (Deborah Guston, J.D.) (Amy Jones, M.S.) RTM2 AMH in the Diagnosis of Polycystic Ovary Syndrome RTM16 Insurance Concerns in Fertility Arrangements (Amani RTM29 Overview on emerging technologies and breakthrough (PCOS)-New Aspects in Development and Diagnosis Hassoun, J.D.) research in Assisted Reproductive Technology (ART) (Joop Laven, M.D., Ph.D.) RTM17 Not-So-Secret “Anonymous Egg Donations”: How Home (Rebecca Krishner, Ph.D.) RTM3 Current Limitations of Semen Analysis (Sergio DNA Testing, Donor Registries, and Social Media Are RTM30 Cryo Tank Failure: What Every REI & Embryologist Should Oehninger, M.D., Ph.D.) Turning the Donor World Upside Down (Will Halm, J.D.) Know (Dawn Kelk, Ph.D., H.C.L.D.) RTM4 REIs and legislative advocacy: Choosing your issues, RTM18 The Current Role of Varicocele Repair in Optimizing Male RTM31 Opening Your Door to Same Sex Male Couples and a finding your voice (Amanda Kallen, M.D.) Fertility and Assisted Reproductive Technology (ART) Process for Your Practice (Mark Leondires, M.D.) RTM5 Conducting Research with SART Data - Setting the Stage Outcomes (Ed Kim, M.D.) RTM32 Cultivating the Use of Social Media in Your Practice for Success (Sangita Jindal, Ph.D.) RTM19 Optimizing Male Fertility Utilizing Lifestyle Modifications (Kenan Omurtag, M.D.) RTM6 Human Oocytes and Embryo Selections (Ping Xia, M.D., (Michael Eisenberg, M.D.) RTM33 Optimal management of Recurrent Pregnancy Loss Ph.D. ) RTM20 The Assisted Reproductive Technology (ART) of Couple (Lia Bernardi, M.D.) RTM7 Fibroids and Other Structural Abnormalities and Satisfaction (Kristy Koser, Ph.D., L.P.C.C.) RTM34 Staying Together for the Kids: Clear Expectations that Pregnancy Loss: The Latest Data and Recommendations RTM21 Surrogacy and the Modern Family: Addressing Partners and Associates Need to Agree Upon in Order (Jennifer Mersereau, M.D.) the Ethical and Emotional Challenges of Complex to Grow the Practice and Avoid Separation RTM8 Nutritional Supplementation for Women with Gestational Surrogacy Cases (Lisa Schuman, L.C.S.W.) (Griffin Jones, B.A.) Endometriosis - What We Know and What We Don’t. RTM22 Calling All Donor Nurse Coordinators: Communication RTM35 Managing Patient Complaints and Setting Expectations (James Nodler, M.D.) and Education of Disclosure Strategies in the Era of (Beth Hume, B.A.) RTM9 Endocrine Disrupting Chemicals and Fertility: An Update 23andMe (Patricia Hershberger, Ph.D., R.N., F.N.P.) RTM36 Intrauterine Adhesion Prevention – a Global and (Carmen Messerlian, Ph.D.) RTM23 How is Your Advanced Practice Provider Best Utilized? Scientific Perspective (Joe Findley, M.D.) RTM10 Fertility Preservation for Men with Benign and Malignant (Hayley Eichlin, D.N.P., A.P.R.N., W.H.N.P.-B.C.) RTM37 Laparoscopic Tissue Extraction Techniques – Pearls to Conditions (Akanksha Mehta, M.D., M.S.) RTM24 Weighing the Evidence on Vitamin D and Reproduction Maximize Success (Zaraq Khan, M.D.) RTM11 Health Disparities and Uterine Fibroids (Erica Marsh, M.D.) (Anne Marie Jukic, Ph.D.) RTM38 Hysteroscopy Fibroid Resection: Pearls for Challenging RTM12 Limits and Complications of Genetic Screening in Egg RTM25 Progress in Comprehensive PGT (Dagan Wells, Ph.D., Cases (Pres Parry, M.D.) Donors (Amber Gamma, M.S., C.G.C.) I.V.I., R.M.A.) RTM39 Estados Asociados Que Modifican El Éxito De RTM13 Utilization and Value of Testicular Sonogram in RTM26 PGT for Late-Onset Disorders (Svetlana Rechitsky, Ph.D.) Implantación (Emilio Valerio, M.D.) Evaluation of Infertility (Richard Levin, M.D.) RTM27 Stem Cell Therapy for Premature Ovarian Insufficiency RTM40 Current State and Individualized Success Rates of Oocyte RTM14 Fertility Preservation in Cancer Patients (Madhuri Patil, M.D.) (Ayman al-Hendy, M.D., Ph.D.) Cryopreservation (Aylin Cil, M.D.)
12:30 pm - 2:00 pm PCC 201C Resident Learning Session Team-based Learning (Ben Hurlburt, Ph.D. and Ranjith Ramasary, M.D.) 1:30 pm - 2:30 pm PCC 103A Interactive Session: Key Performance Indicators for the IVF Lab (Amy Sparks, Ph.D.; Alison Bartolucci, M.S.; and Dean Morbeck, Ph.D., M.B.A., H.C.L.D.) 1:30 pm - 2:30 pm PCC 103B Interactive Session: How Do We Reach the Goal of Universal Insurance Coverage for IVF? (Jacqueline Ho, M.D.; Sean Tipton, M.A.; Erin Kramer, B.A.; and Barbara Collura, M.A) 1:30 pm - 2:30 pm PCC 105AB Interactive Session: An Integrative Approach to Treating Dysmenorrhea Associated with Endometriosis (Peter Harvey, M.B.A.,L.Ac., F.A.B.O.R.M.; and Charles E. Miller M.D.) 1:30 pm - 2:30 pm PCC 107AB Interactive Session: No Satisfaction: Psychological and Medical Perspectives on Infertility and Sexual Dysfunction (William D. Petok, Ph.D.; Elizabeth A. Grill, Psy.D.; Robert D. Oates, M.D.; and Kim Bergman, Ph.D.) 1:30 pm - 2:30 pm PCC 108A Interactive Session: Moving Hysteroscopy from the Operating Room to the Office: Essentials for Success, Safety, and Patient Satisfaction (Steven R. Lindheim, M.D.; Stefano Bettocchi, M.D.; Keith Isaacson, M.D.; and Brad Senstra, M.H.A.) 1:30 pm - 2:30 pm PCC 108B Interactive Session: Non-invasive Preimplantation Genetic Testing (NIPGT): Is it Applicable for ART Practice? (Svetlana Rechitsky, Ph.D.; Dagan Wells, Ph.D., I.V.I., R.M.A.; and Carlos Rubio, Ph.D.) 1:30 pm - 2:30 pm PCC 204A Interactive Session: Counseling Patients on Mosaicism (JoRene Bigler-Vollman, R.N., M.S.N.; Lisa A. Rinehart, J.D., R.N.; and Andria G. Besser, M.S., C.G.C) 1:30 pm - 2:30 pm PCC 103C Interactive Session: Best Practices in Miscarriage Management (Courtney Schreiber, M.D.; Sarah Horvath, M.D.; Sarita Sonalkar, M.D., M.P.H.; and Vanessa Dalton, M.D., M.P.H.)
1:30 pm - 2:30 pm PCC 201A MHPG Clinical Session: The Trauma of Infertility and Pregnancy Loss: Helping Our Patients Heal (Janet Jaffe, Ph.D.; Karen Hall, Ph.D.; and Julie Bindeman, Psy.D.) 2:35 pm - 3:20 pm PCC Ballroom AB Lecture: IVF as a Business (David Sable, M.D.) 2:35 pm - 3:20 pm PCC Exhibit Hall C Lecture: The David and Rosemary Adamson Lecture on Excellence in Reproductive Medicine: Midnight’s Broken Toll: Male Fertility and the Health of Future Generations (R. John Aitken, Ph.D., Sc.D., F.R.S.E., F.R.S.N., F.A.H.M.S., F.A.A.)
3:20 pm - 4:15 pm PCC Expo Hall Break – Join us for this special break and celebrate ASRM’s 75th Anniversary with a festive toast and cake. 4:15 pm - 5:30 pm PCC Exhibit Hall C Symposium: ABOG - Kenneth J. Ryan Ethics Symposium: Ethics in Embryo Research: In Consideration of Patients, Progeny and Professional Norms (Alto Charo, J.D.; Ben Hurlbut, Ph.D.; and Feng Zhang, Ph.D.) 4:15 pm - 5:30 pm PCC 201B Symposium: Are Specialized Sperm Function Tests Clinically Useful? (Armand Zini, M.D., F.R.C.S.C.; Sandro Esteves, M.D., Ph.D., M.Sc.; and Douglas T. Carrell, Ph.D.) 4:15 pm - 5:30 pm PCC 103A Symposium: New Updates on Therapies for Infertility in Polycystic Ovary Syndrome (PCOS) (Juha Tapanainen, M.D., Ph.D.; Richard S. Legro, M.D.; and Joop B.E. Laven, M.D., Ph.D.) 4:15 pm - 5:30 pm PCC 103B Symposium: Management of Infertility in Low Resource Settings (Christopher Herndon, M.D.; Julia V. Johnson, M.D.; Sheryl Vanderpoel, Ph.D.; Kevin J. Doody, M.D.; and Melissa Harmon, R.N.) 4:15 pm - 5:30 pm PCC 201A Symposium: The New Modern Family: Family-building and Co-parenting in the 21st Century (Linda Kondilis, Psy.D.; Laurie McKenzie, M.D.; Heather Ross, J.D.) 4:15 pm - 5:30 pm PCC 204A Symposium: Ovarian Tissue Cryopreservation and Transplantation: 20 Years of Progress (Kutluk H. Oktay, M.D., Ph.D.; Isabelle Demeestere, M.D., Ph.D.; and Nao Suzuki, M.D., Ph.D.) 4:15 pm - 5:30 pm PCC 105AB Symposium: How to Build High Functioning Teams in the Embryology Lab (Blake R. Welch, M.B.A. and David Ball, Ph.D.) 4:15 pm - 5:30 pm PCC Ballroom AB Symposium: The Endometrium and Recurrent Pregnancy Loss (Sony Sierra, M.D., M.Sc., F.R.C.S.C.; Steven L. Young, M.D., Ph.D.; and Arri Coomarasamy, Ph.D.) 4:15 pm - 5:30 pm PCC 107AB Symposium: ESHRE Symposium: Looking Beyond the XX Factor (Jackson Kirkman-Brown, M.B.E. and Adelheid Soubry, Ph.D.) 4:15 pm - 5:30 pm PCC 108B Symposium: ISAR Symposium: Genital Kochs and Infertility (Hrishikesh Pai, M.D., M.Sc.; Jaideep Malhotra, M.B.B.S., M.D.; Madhuri Patil, M.D.; Firuza Parikh, M.D., D.N.B., Ph.D.; Rishma Dhillon Pai, M.D.) 4:15 pm - 5:30 pm PCC 103C Symposium: MEFS Symposium: Controversies in ART (Botros Rizk, M.D., M.A., F.R.C.O.G., F.R.C.S.(C), H.C.L.D., F.A.C.O.G., F.A.C.S.; Richard J. Paulson, M.D., M.S.; and Bruce Shapiro, M.D., Ph.D., H.C.L.D.) 4:15 pm - 5:30 pm PCC 108A Symposium: SSR Symposium: Fertility Preservation- Existing and Emerging Fertility Preservations Options for Women and Men (Mary B. Zelinski, Ph.D.; So-Youn Kim, PhD.; and Kyle E. Orwig, Ph.D.)
4:15 pm - 5:30 pm PCC 201C Video Program Prize Session
5:30 pm - 7:00 pm PCC 106A Male Reproductive Research Group (Andrology Research Consortium)
Members’ Meetings 5:45 pm - 6:30 pm PCC 204A Uterine Transplant Members’ Meeting PCC103A Androgen Excess Special Interest Group (AESIG) PCC 104A Menopause and Ovarian Insufficiency Special Interest Group PCC 103B Access to Care PCC 105AB Endometriosis Special Interest Group PCC 201A LGBTQ Special Interest Group PCC 106B Regenerative Medicine Special Interest Group PCC 104B Physician Scientists Special Interest Group PCC 107AB Pediatric and Adolescent Gynecology Special Interest Group PCC 108A Nutrition Special Interest Group PCC 108B Indian Special Interest Group PCC 112AB Reproductive Immunology Special Interest Group PCC 201C Health Disparities Special Interest Group PCC 109AB Complementary and Integrative Medicine Special Interest Group PCC 201B Legal Professional Group Members’ Meeting
5:45 pm - 7:00 pm PCC 103C Society for Assisted Reproductive Technology 6:15 pm - 7:00 pm Marriot 403 Fertility Preservation Special Interest Group 6:15 pm - 8:00 pm Marriot 407 SRS Members’ Meeting and Reception
Monday Oct 14.indd 2 9/9/19 10:02 AM